Massachusetts is trying an experiment where the state will pay for one of the most expensive drugs on the market, but will get its money back if it doesn't work. Massachusetts is "blazing a trail that every other state is watching and saying, if Massachusetts can make this work, we think we can do it too," said Matt Salo, executive director at the National Association of Medicaid Directors.
from Kaiser Health News https://ift.tt/31y4tzr
February 07, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Some County Jail Inmates See Vaccination as Ticket to a Better Life — In the State PenLOS ANGELES — The inmates huddled near the front or lingered on the bunk beds lining both sides of their narrow, crowded dorm at the Men’s Central Jail, listening as Lt. Sheriff Dwight Miley and nurse practitioner Marissa Neg… Read More
Covid Forces Cohousing Communities to Examine Shared Values and RelationshipsTensions were running high at PDX Commons, a cohousing community for adults 55 and older in Portland, Oregon. Several people wanted to keep visitors off-site until all 35 residents were vaccinated. Others wanted to open to fa… Read More
KHN’s ‘What the Health?’: 100 Days of Health PolicyCan’t see the audio player? Click here to listen on SoundCloud. It’s been a busy 100 days for the Biden administration on health policy. The promise Joe Biden made as president-elect to get 100 million covid vaccinations… Read More
The Vulnerable Homebound Are Left Behind on VaccinationIt was April, more than three months into the vaccination campaign against covid-19, and Jim Freeman, 83, still had not gotten his first dose. Use Our Content It can be republished for free. Freeman had been eligible for mont… Read More
A ‘Dose of Hope’? Fact-Checking President Joe Biden’s First Speech to CongressIn his first speech before Congress, President Joe Biden argued it was time to turn the coronavirus pandemic into a historic opportunity to expand government for the benefit of a wider range of Americans, urging investments i… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment